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Mycobacteria can diminish allergic and asthmatic manifestations. This means that
mycobacteria could offer therapeutical opportunities as an ‘anti-allergic’ vaccine.
In humans, the genetic background and the environment probably contribute to the
development of allergies. Over the last 20 years, a popular explanation for the increase in
allergies is the ‘hygiene hypothesis’. This hypothesis argues that there might be a misbal-
ance in T-helper-type responses or a misbalance in regulatory immune responses due to
less microbial stimulation. It is clear that the hygiene hypothesis should involve the genetic
and the environmental background of the individual. Up until now, no specific infectious
factor has been found that could explain the hygiene hypothesis. However, interesting data
have been obtained in animal models that could support the hygiene hypothesis. These
studies also support that mycobacterial treatment results in regulatory mechanisms that
restored the immune balance.
In this presentation, the most recent basic and clinical findings concerning mycobacte-
rium and allergic diseases will be highlighted.
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